Prescribing
The NHS Cheshire and Merseyside Area Prescribing Group (APG) and its subgroups provide a framework to coordinate the integration of safe, clinically effective and cost-effective medicines across Cheshire and Merseyside. Improved outcomes and an improved experience for patients are central to the decision-making process.
The APG is a professional group consisting of GPs, pharmacists, and other key healthcare professionals who are responsible for ensuring robust standards and governance for decision-making.
-
Policies
APG policy, APG terms of reference and more
-
APG subgroups
New medicines, Formulary and guidelines, Interface prescribing, Safety, and Antimicrobial guide
-
Forms and applications
New service developments, individual funding requests, and appeals process
-
Reports
APG approvals reports and more
-
Wegovy™ access in Cheshire and Merseyside
Wegovy® (Semaglutide) – a weight-management treatment – is currently only available to NHS patients via specialist Tier 3 or 4 weight management services
-
Valproate
New regulatory measures for oversight of prescribing to new patients and existing female patients
-
Update on ADHD medication shortage
Attention deficit hyperactivity disorder (ADHD) medication shortages affecting the UK
-
Treatment of indigestion with Proton Pump Inhibitors (PPIs)
Patient Information including lifestyle advice and advice for stopping or stepping down PPI treatment for indigestion.
Contact
For medicines optimisation enquiries, please email: Mop-enquiries@cheshireandmerseyside.nhs.uk